dermatology Archives -

Lilly swoops on Dermira to claim Dupixent rival

https://pharmaphorum.com/news/lilly-swoops-on-dermira-to-claim-dupixent-rival/

Ligelizumab could top Xolair in chronic hives, says Novartis

https://pharmaphorum.com/news/ligelizumab-could-top-xolair-in-chronic-hives-says-novartis/

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

https://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/

3rd Annual Dermatology Drug Development Summit

https://pharmaphorum.com/events/3rd-annual-dermatology-drug-development-summit/

Sanofi ups revenues forecasts as eczema drug Dupixent surges

https://pharmaphorum.com/news/sanofi-ups-revenues-forecasts-as-eczema-drug-dupixent-surges/

https://pharmaphorum.com/events/your-ultimate-guide-to-the-skin-microbiome/

Almirall takes option on Dermira’s eczema drug lebrikizumab

https://pharmaphorum.com/news/almirall-takes-option-on-dermiras-eczema-drug-lebrikizumab/

AbbVie gets crucial US approval for psoriasis drug Skyrizi

https://pharmaphorum.com/news/abbvie-gets-crucial-us-approval-for-psoriasis-drug-skyrizi/

Almirall signs atopic dermatitis R&D deal with Hitgen

https://pharmaphorum.com/news/almirall-signs-atopic-dermatitis-rd-deal-with-hitgen/

Search